Services

services

services

Brammer’s CDMO business is focused on providing development and manufacturing services for cell and gene therapies through a range of platform technologies. These include a full suite of services for autologous cell therapy, allogeneic cell therapy, ex vivo gene therapy, and viral vector manufacturing.

Learn More

About Us

about us

about us

Brammer’s focus is on flexibility in our approach to relationships and services for companies seeking to develop and commercialize cell and gene therapies. We aim to enable clients to fulfill their missions to improve patient health through excellence in process development, analytical development, and clinical and commercial manufacturing and supply.

Learn More

Our People

Our people

Our people

Brammer Bio was founded and is managed by a team experienced in the operation of successful, state-of-the-art, commercial-ready CDMOs and in building strong client relationships ranging from large pharmaceutical and biotech companies and cell and gene therapy-focused specialty biotechs.

Learn More